Insiders Trades
Alexion Pharmaceuticals Inc Stock: price and insider trades · United States
Alexion Pharmaceuticals Inc: what insiders have been doing
This page follows insider dealings at Alexion Pharmaceuticals Inc as filed with SEC (Form 4) based in Cheshire, United States. The group dates from 1992. No insider at Alexion Pharmaceuticals Inc has published a filing in the past twelve months. The most recent one dates from 23 July 2021.
Our records for Alexion Pharmaceuticals Inc go back to 2016, with no purchases and 90 sales on the open market in total.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
136
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
90 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2020FY ended December 2020 · cache
Income statement
RevenueUS$5.3B
Net incomeUS$522.4M9.9% margin
Last declaration on 23 July 2021
Declarations136 total
15,336 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000071:0
116,075 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000066:0
13,921 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000065:0
12,840 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000075:0
580,809 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000063:0
14,150 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000074:0
146,511 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000062:0
28,109 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000064:0
42,347 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000077:0
14,629 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000073:0
120,253 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000076:0
116,850 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000068:0
60,207 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000067:0
20,873 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000070:0
150,832 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000069:0
59,226 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000072:0
30,643 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000051:0
30,643 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000054:0
120,894 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000058:0
26,812 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000056:0
11,060 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000055:0
25,813 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000052:0
26,812 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000057:0
26,812 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000053:0
928 shares@ US$177.00100.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-21-000048:0
25 of 136 declarations
About Alexion Pharmaceuticals Inc
Alexion Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for rare and severe diseases. It specializes in the research and commercialization of innovative drugs to improve patients' lives.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
